Endothelin-1 Governs Proliferation and Migration of Bronchoalveolar Lavage-Derived Lung Mesenchymal Stem Cells in Bronchiolitis Obliterans Syndrome
Authors:
- Mohamed SalamaMSMohamed Salama
- Olena AndrukhovaOAOlena Andrukhova
- Peter JakschPJPeter Jaksch
- Shahrokh TaghaviSTShahrokh Taghavi
- Walter KelpetkoWKWalter Kelpetko
- Gerhard DekanGDGerhard Dekan
- Seyedhossein AharinejadSASeyedhossein Aharinejad
- 27 July 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 92 (2) , 155-162
Abstract
Bronchiolitis obliterans syndrome (BOS) has an incidence of 57% at 5 years after lung transplantation, accounts for 30% of all deaths 3 years posttransplant and because treatment options are extremely limited, it constitutes a significant health care problem. Adult mesenchymal stem cells (MSCs) play a role in lung turnover; however, their role in BOS remains unknown. MSCs were isolated from bronchoalveolar lavage (BAL) in 101 lung allograft recipients. BAL was screened by protein array and MSCs were analyzed by real-time polymerase chain reaction, proliferation, migration, and enzyme linked immunosorbent assays. Multipotent MSCs were isolated from BAL of lung recipients independent of BOS presence. However, MSCs from BOS patients proliferated at higher rates (PConclusions. These results indicate that MSCs are associated with BOS and are governed by ET-1. Targeting MSCs by ET-1 blockade might be useful in BOS treatment.Keywords
This publication has 25 references indexed in Scilit:
- Mesenchymal Stromal Cells in Bronchoalveolar Lavage as Predictors of Bronchiolitis Obliterans SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Endothelin-1 is a useful biomarker for early detection of bronchiolitis obliterans in lung transplant recipientsThe Journal of Thoracic and Cardiovascular Surgery, 2010
- The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report—2009The Journal of Heart and Lung Transplantation, 2009
- Acute Cellular Rejection Is a Risk Factor for Bronchiolitis Obliterans Syndrome Independent of Post-transplant Baseline FEV1The Journal of Heart and Lung Transplantation, 2009
- Update in Lung Transplantation 2008American Journal of Respiratory and Critical Care Medicine, 2009
- Lung Resident Mesenchymal Stem Cells Isolated from Human Lung Allografts Inhibit T Cell Proliferation via a Soluble MediatorThe Journal of Immunology, 2008
- Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptorsTransplant Immunology, 2008
- Course of FEV1 after Onset of Bronchiolitis Obliterans Syndrome in Lung Transplant RecipientsAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allograftsJournal of Clinical Investigation, 2007
- Bronchiolitis Obliterans SyndromeDrugs, 2005